Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

Nat Commun. 2023 Oct 5;14(1):6211. doi: 10.1038/s41467-023-42061-4.

Payton A-B Weidenbacher^#^{1

2}, Mrinmoy Sanyal^#^{1

3}, Natalia Friedland^#^{1

3}, Shaogeng Tang^{1

3}, Prabhu S Arunachalam⁴, Mengyun Hu⁴, Ozan S Kumru⁵, Mary Kate Morris⁶, Jane Fontenot⁷, Lisa Shirreff⁷, Jonathan Do^{1

3}, Ya-Chen Cheng^{1

3}, Gayathri Vasudevan⁸, Mark B Feinberg⁸, Francois J Villinger⁷, Carl Hanson⁶, Sangeeta B Joshi⁵, David B Volkin⁵, Bali Pulendran^{4

9

10}, Peter S Kim^{11

12

13}

¹ Sarafan ChEM-H, Stanford University, Stanford, CA, USA.
² Department of Chemistry, Stanford University, Stanford, CA, USA.
³ Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA.
⁴ Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
⁵ Vaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA.
⁶ California Department of Public Health, Richmond, CA, USA.
⁷ New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA.
⁸ IAVI, New York, NY, USA.
⁹ Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
¹⁰ Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
¹¹ Sarafan ChEM-H, Stanford University, Stanford, CA, USA. kimpeter@stanford.edu.
¹² Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA. kimpeter@stanford.edu.
¹³ Chan Zuckerberg Biohub, San Francisco, CA, 94158, USA. kimpeter@stanford.edu.

^# Contributed equally.

No abstract available

Publication types